Ontology highlight
ABSTRACT:
SUBMITTER: Cheema PK
PROVIDER: S-EPMC6380636 | biostudies-literature | 2019 Feb
REPOSITORIES: biostudies-literature
Current oncology (Toronto, Ont.) 20190201 1
For more than a decade, there has been no improvement in outcomes for patients with unresectable locally advanced (la) non-small-cell lung cancer (nsclc). The standard treatment in that setting is definitive concurrent chemotherapy and radiation (ccrt). Although the intent of treatment is curative, most patients rapidly progress, and their prognosis is poor, with a 5-year overall survival (os) rate in the 15%-25% range. Those patients therefore represent a critical unmet need, warranting expedit ...[more]